760-4529 MUM1 (MRQ-43) PAB cell marque
Ended Awarded Last action
- Contract number
- 75N91019F00135
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,200
Award facts
- Opportunity
-
- N02PCSS21317 Solicitation number
- Reagents and consumables for Ventana Medical Systems (VMS) Benchmark Ultra immunostainers Award Notice · Posted Feb 13, 2017
- Contract value 100% obligated
- $19,200.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $19,200 |
Quick answers
Who was awarded contract 75N91019F00135?
75N91019F00135 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on March 21, 2019.
How much is contract 75N91019F00135 worth?
The government has obligated $19,200 on 75N91019F00135.
Is contract 75N91019F00135 an order under another contract?
Yes. 75N91019F00135 is a delivery order under HHSN261201700010I, an indefinite delivery contract.
Was contract 75N91019F00135 competed?
The extent of competition for 75N91019F00135 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award